院内心脏骤停复苏后炎症反应与良好神经功能结局的相关性
本研究为单中心观察性研究,纳入2014年3月至2019年5月期间在学术三级医疗中心接受ACLS指导复苏的105例成人IHCA患者,在骤停后6、24、48、72、96小时检测15种细胞因子。主要终点为出院时良好神经功能结局(Glasgow Outcome Score 4或5),27例(25.7%)达到。良好结局组6或24小时内IL-6、IL-8、IL-10和TNF-R1水平显著较低,多变量分析中仅6小时内IL-10为独立预测因素(OR 0.895,95%CI 0.805-0.996,p=0.041)。结论提示早期炎症细胞因子可用于IHCA预后判断,但需进一步大样本研究验证。
要点
- 在105例成人IHCA患者中,出院时良好神经功能结局(GOS 4-5)占25.7%(27例),不良结局占74.3%(78例)。
- 良好神经功能结局组6或24小时内IL-6、IL-8、IL-10和TNF-R1水平显著低于不良结局组。
- 多变量分析中,6小时内IL-10水平是良好神经功能结局的唯一独立预测因素(OR 0.895,95%CI 0.805-0.996,p=0.041)。
- 良好结局组男性比例更高(88.9% vs 61.5%,p=0.008),初始心律为室性快速性心律失常的比例更高(34.6% vs 11.7%,p=0.018)。
- 该研究为单中心观察性研究,样本量较小(105例),作者指出需更大规模研究验证这些细胞因子与预后的关联。
适用人群与场景
- 纳入2014年3月至2019年5月在学术三级医疗中心接受ACLS指导复苏的成人院内心脏骤停(IHCA)患者。
- 排除标准原文未提及。
诊断标准与关键阈值
- 良好神经功能结局定义为出院时Glasgow Outcome Score为4或5。
- 细胞因子检测时间点为IHCA后6、24、48、72和96小时。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:单中心观察性研究;样本量105例成人IHCA患者;无多中心数据。
- 主要终点:出院时良好神经功能结局(GOS 4或5)发生率为25.7%(27/105),不良结局为74.3%(78/105)。
- 良好结局组与不良结局组比较:男性比例88.9% vs 61.5%(p=0.008),初始心律为室性快速性心律失常比例34.6% vs 11.7%(p=0.018)。
- 6或24小时内IL-6、IL-8、IL-10和TNF-R1水平在良好神经功能结局组显著低于不良结局组。
- 多变量分析中,6小时内IL-10水平是良好神经功能结局的唯一独立预测因素(OR 0.895,95%CI 0.805-0.996,p=0.041)。
证据类型、等级与局限
- 证据类型:单中心观察性研究。
- 证据等级或推荐强度:原文未提及。
- 局限:单中心、样本量较小(105例)、观察性设计;作者指出需更大规模研究验证。
对床旁实践的改变
- 本研究提示成人IHCA后早期(6小时内)IL-10水平可能与良好神经功能结局相关,但仅为单中心观察性研究结果,尚不能作为床旁决策阈值。
- 原文未提供基于细胞因子的治疗推荐或流程改变。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early prediction of mortality in adults after in-hospital cardiac arrest (IHCA) remains vital to optimizing treatment strategies. Inflammatory cytokines specific to early prognostication in this population have not been well studied. We evaluated whether novel inflammatory cytokines obtained from adults with IHCA helped predict favorable neurologic outcome.
METHODS: The study population included adults with IHCA who underwent ACLS-guided resuscitation between March 2014 and May 2019 at an academic tertiary medical center. Peripheral blood samples were obtained within 6, 24, 48, 72, and 96 h of IHCA and analysis of 15 cytokines were performed. The primary outcome of interest was presence of favorable neurologic outcome at hospital discharge, defined as a Glasgow Outcome Score of 4 or 5.
RESULTS: Of the 105 adults with IHCA studied, 27 (25.7%) were noted to have survival with a favorable neurologic outcome while 78 (74.3%) did not. Patients who survived with favorable neurologic outcome were more often men (88.9% vs 61.5%, p = 0.008) and had higher rates of ventricular tachyarrhythmias as their initial rhythm (34.6% vs 11.7%, p = 0.018). Levels of interleukin (IL)-6, IL-8, IL-10, and Tumor Necrosis Factor (TNF)-R1 within 6 or 24 h were significantly lower in patients with favorable neurologic outcome compared with those who had unfavorable neurologic outcome. In multivariable analysis, IL-10 levels within 6 h was the only independent predictor of favorable neurologic outcomes [odds ratio (OR) 0.895, 95% confidence interval 0.805-0.996, p = 0.041].
CONCLUSION: In this contemporary observational study of adults with IHCA receiving ACLS-guided resuscitative and post-resuscitative care, inflammatory cytokines specific to early prognostication in adults with IHCA exist. Further larger scale studies examining the association of these inflammatory cytokines with prognosis are warranted.
参考来源
- Patel JK, Sinha N, Hou W, et al. Association of post-resuscitation inflammatory response with favorable neurologic outcomes in adults with in-hospital cardiac arrest. Resuscitation. 2020. PMID: 33385467. doi:10.1016/j.resuscitation.2020.12.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。